Clinical Trial Update: Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety, tolerability, and pharmacodynamics of AZR-MD-001 in contact lens discomfort has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contact Lens Discomfort

Drugs mentioned

• AZR-MD-001

Snippet

Sponsor: Azura Ophthalmics | Conditions: Contact Lens Discomfort | Phase 2 | Status: COMPLETED